HALIFAX, NS / ACCESS Newswire / / Namibia Critical Metals Inc. ("Namibia Critical Metals" or the "Company" or "NMI") ...

HALIFAX, NS / ACCESS Newswire / December 3, 2025 / Namibia Critical Metals Inc. ("Namibia Critical Metals" or the "Company" or "NMI") is pleased to announce the results of its Pre-Feasibility Study (" ...

Robust and clinically meaningful benefits across all three key markers of disease - 68% reduction in proteinuria, stabilization of kidney function, and substantial clearance of C3 depositsConsistent ...

In an exclusive interview, Alterity Therapeutics’ ( ATHE) CEO David Stamler met with The Fly to discuss the company, the biotech industry, ongoing trials, upcoming milestones and much more. Published ...

Patients who used specific immune-boosting herbs before the onset of dermatomyositis had lower rates of autoantibodies, leading researchers to believe they may trigger dermatomyositis through ...

Narryer Metals Limited ( ($AU:NYM) ) has shared an announcement. Narryer Metals Limited announced promising results from a metallurgical study on ...

MSA Safety (NYSE:MSA) delivered third-quarter numbers that came in above market expectations, with both sales and earnings up from a year ago. The company also reaffirmed its full-year guidance in its ...

Shares of safety equipment manufacturer MSA Safety (NYSE:MSA) fell 5.1% in the morning session after the company reported third-quarter results that showed declining profit margins and persistent ...

Sitting has often been referred to as the new smoking thanks to its negative health benefits. For the first time ever, according to researchers in England, the flavanols in cocoa have been found to ...

Charitable organizations have seen giving by the affluent increase significantly, but the number of donors is shrinking. That is the conclusion of the Bank of America Study of Philanthropy, which was ...

BOSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its ...

MSA is a rare, rapidly progressive neurodegenerative disorder affecting the body’s movement, balance, and autonomic functions. Classified as an orphan disease by the FDA, MSA affects an estimated ...